Short-course radiation plus chemotherapy for endometrial cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This early-phase study tests whether giving a short course of radiation together with chemotherapy can help treat endometrial cancer after surgery. It aims to find a treatment plan that is effective while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed endometrial cancer of an eligible cell type (several specific types are allowed).
- You already had surgery that removed the uterus (hysterectomy) and both ovaries and fallopian tubes, and had lymph node checks in the pelvis.
- Your cancer stage is FIGO IIIA or IIIC1 based on that surgical staging.
- Your surgery was no more than 12 weeks ago, and there is no visible cancer left after surgery.
- You have not had chemotherapy or radiation for endometrial cancer before starting this study.
- Your lab tests and general strength are good enough (blood counts, liver/kidney numbers, and ability to do daily activities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using MRI scans daily during pelvic radiation therapy improves treatment precision and outcomes for endometrial cancer patients who need radiation after surgery. The goal is to better target cancer while reducing side effects.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This trial tests a shorter course of pelvic radiation for people with endometrial cancer after surgery. It aims to see if it is safe, works well, and improves quality of life.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
This trial tests a precise type of radiation (stereotactic radiotherapy) given after surgery for endometrial cancer. It aims to improve treatment while reducing side effects.
This study compares different ways of giving radiation and chemotherapy after surgery for stage III endometrial (uterine) cancer. It aims to find which approach works best to reduce cancer risk and improve outcomes.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.